Literature DB >> 27695180

Acute renal failure due to vancomycin toxicity in the setting of unmonitored vancomycin infusion.

Shagufta Vora1.   

Abstract

Vancomycin-induced nephrotoxicity is a commonly feared and largely preventable adverse effect of vancomycin therapy. We present the case of a 56-year-old woman who developed acute renal failure requiring hemodialysis as a result of unmonitored vancomycin infusions for the treatment of osteomyelitis.

Entities:  

Year:  2016        PMID： 27695180      PMCID： PMC5023302          DOI： 10.1080/08998280.2016.11929491

Source DB:  PubMed          Journal:  Proc (Bayl Univ Med Cent)        ISSN： 0899-8280


  10 in total

Review 1.  Vancomycin-induced nephrotoxicity: mechanism, incidence, risk factors and special populations. A literature review.

Authors:  Sepideh Elyasi; Hossein Khalili; Simin Dashti-Khavidaki; Amirhooshang Mohammadpour
Journal:  Eur J Clin Pharmacol       Date:  2012-03-13       Impact factor: 2.953

2.  Comparison of the incidence of vancomycin-induced nephrotoxicity in hospitalized patients with and without concomitant piperacillin-tazobactam.

Authors:  Lindsey D Burgess; Richard H Drew
Journal:  Pharmacotherapy       Date:  2014-05-22       Impact factor: 4.705

3.  Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society Of Infectious Diseases Pharmacists.

Authors:  Jennifer H Martin; Ross Norris; Michael Barras; Jason Roberts; Ray Morris; Matthew Doogue; Graham R D Jones
Journal:  Clin Biochem Rev       Date:  2010-02

Review 4.  Vancomycin and the kidney.

Authors:  G B Appel; D B Given; L R Levine; G L Cooper
Journal:  Am J Kidney Dis       Date:  1986-08       Impact factor: 8.860

5.  Risk factors for acute kidney injury in adult patients receiving vancomycin.

Authors:  Diane Cappelletty; Alyse Jablonski; Rose Jung
Journal:  Clin Drug Investig       Date:  2014-03       Impact factor: 2.859

Review 6.  Vancomycin dosing and monitoring 2 years after the guidelines.

Authors:  Ben M Lomaestro
Journal:  Expert Rev Anti Infect Ther       Date:  2011-06       Impact factor: 5.091

7.  Nephrotoxicity of vancomycin, alone and with an aminoglycoside.

Authors:  M J Rybak; L M Albrecht; S C Boike; P H Chandrasekar
Journal:  J Antimicrob Chemother       Date:  1990-04       Impact factor: 5.790

8.  Vancomycin-associated nephrotoxicity in adult medicine patients: incidence, outcomes, and risk factors.

Authors:  Calvin J Meaney; Lauren M Hynicka; Mona G Tsoukleris
Journal:  Pharmacotherapy       Date:  2014-04-03       Impact factor: 4.705

Review 9.  Vancomycin-associated renal dysfunction: where are we now?

Authors:  Joseph J Carreno; Rachel M Kenney; Ben Lomaestro
Journal:  Pharmacotherapy       Date:  2014-09-15       Impact factor: 4.705

10.  Successful utilization of high-flux hemodialysis for treatment of vancomycin toxicity in a child.

Authors:  Timothy Stidham; Pamela D Reiter; Douglas M Ford; Gary M Lum; Joseph Albietz
Journal:  Case Rep Pediatr       Date:  2012-01-29
  10 in total
  3 in total

1.  Kidney Damage and Stress Biomarkers for Early Identification of Drug-Induced Kidney Injury: A Systematic Review.

Authors:  Ravi J Desai; Christina L Kazarov; Adrian Wong; Sandra L Kane-Gill
Journal:  Drug Saf       Date:  2022-07-13       Impact factor: 5.228

2.  Augmented Renal Clearance in a Case of Sepsis Leading to Vancomycin Failure Despite Increasing Dose As per the Estimated Glomerular Filtration Rate.

Authors:  Rama Kanth Pata; Chhabilal Bastola; Nway Nway; Meet J Patel; Samaj Adhikari
Journal:  Cureus       Date:  2021-03-30

3.  Association between fluid infusions and the recovery from acute kidney injury in patients administered liposomal amphotericin B: a nationwide observational study.

Authors:  Masato Tashiro; Yoko Obata; Takahiro Takazono; Yuki Ota; Tomotaro Wakamura; Yui Shiozawa; Ai Tsuyuki; Taiga Miyazaki; Tomoya Nishino; Koichi Izumikawa
Journal:  Ren Fail       Date:  2022-12       Impact factor: 2.606
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.